Related Experiment Video
Updated: Jan 8, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Hybrid Extracellular Vesicles for Efficient Loading and Functional Delivery of mRNA
Xiaoqin Wang1,2, Michael J Munson2, Kristina Friis2
1Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Researchers developed hybrid extracellular vesicles (HEVs) for mRNA delivery. These HEVs overcome loading challenges and improve intracellular mRNA delivery, showing promise for therapeutic applications.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Extracellular vesicles (EVs) are promising drug delivery vehicles.
- Challenges exist in loading and functional delivery of mRNA using EVs.
- Lipid nanoparticles (LNPs) offer alternative delivery but have limitations.
Purpose of the Study:
- To develop a novel hybrid extracellular vesicle (HEV) platform for enhanced mRNA delivery.
- To investigate the mechanism of mRNA loading and intracellular delivery by HEVs.
- To evaluate the in vivo efficacy and biodistribution of HEV-mediated mRNA delivery.
Main Methods:
- Engineered hybrid EVs (HEVs) by fusing EVs with LNPs using low pH-induced fusion.
- Characterized HEVs using conventional methods and single particle analysis.
- Assessed HEV cell tolerability, mRNA loading efficiency, and intracellular delivery mechanisms.
- Evaluated in vivo mRNA delivery and biodistribution in a preclinical model.
Main Results:
- HEVs successfully incorporated mRNA and LNP components while retaining EV characteristics.
- HEVs demonstrated improved cell tolerability and efficient mRNA delivery compared to native EVs.
- HEVs facilitated endosomal escape, enhancing intracellular mRNA delivery.
- In vivo studies showed functional extrahepatic mRNA delivery, primarily to the spleen.
Conclusions:
- Hybrid EVs (HEVs) represent a novel and effective platform for mRNA delivery.
- HEVs overcome key limitations of traditional EVs and LNPs for mRNA therapeutics.
- The HEV platform shows significant potential for advancing mRNA-based therapies.
More Related Videos
10:02Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Related Concept Videos
Regulated mRNA Transport
Nuclear Export of mRNA
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Intralumenal Vesicles and Multivesicular Bodies